LATANOPROST - A NEW PROSTAGLANDIN-F2-ALPH A ANALOG IN GLAUCOMA THERAPY - A SURVEY

An ideal glaucoma drug reduces intraocular pressure profoundly and lon g-lastingly without known major side effects: Latanoprost, a new prost aglandin F-2 alpha-analogue, indeed has these properties. However, we need long-term experience to exclude major, clinically relevant side e ffects. The influence of latanoprost on ocular circulation also needs further evaluation. Nevertheless. the clinician does have a new and ve ry potent drug to reduce intraocular pressure. Literature search by Me dline.